Cargando…

In vitro osteolytic activity of human breast carcinoma tissue and prognosis.

Detalles Bibliográficos
Autores principales:	Dady, P. J., Powles, T. J., Dowsett, M., Easty, G., Williams, J., Neville, A. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1981
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010522/ https://www.ncbi.nlm.nih.gov/pubmed/7470384

Ejemplares similares

The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer
por: Powles, T. J., et al.
Publicado: (1973)

Measurement of the Ability of Cells to Infiltrate Normal Tissues In vitro
por: Easty, D. M., et al.
Publicado: (1974)

Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1996)

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.
por: Rossi, J. F., et al.
Publicado: (1984)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Treatment of breast cancer with aromatase inhibitors--current status and future prospects.
por: LÃ¸nning, P. E., et al.
Publicado: (1989)

Effects of endocrine therapy on steroid-receptor content of breast cancer.
por: Taylor, R. E., et al.
Publicado: (1982)

Macromolecular osteolytic factor synthesised by squamous carcinoma cell lines from the head and neck in vitro is interleukin 1.
por: Meghji, S., et al.
Publicado: (1988)

An assessment of the effects of hormones on short term organ cultures of human breast carcinomata.
por: Beeby, D. I., et al.
Publicado: (1975)

Multiple Osteolytic Lesions
por: Vinayachandran, Divya, et al.
Publicado: (2013)

Osteolytic lesions in myelofibrosis
por: Johnson, Isla, et al.
Publicado: (2021)

Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck.
por: Easty, D. M., et al.
Publicado: (1981)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
por: Liapis, Vasilios, et al.
Publicado: (2016)

Primary intraosseous osteolytic meningioma without an evidence of soft tissue invasion
por: Dolachee, Ali Adnan, et al.
Publicado: (2020)

Tuberculosis of the foot: An osteolytic variety
por: Dhillon, Mandeep S, et al.
Publicado: (2012)

Solitary Tibial Osteolytic Lesion
por: Pakos, Emilios E., et al.
Publicado: (2009)

Pathological fracture on osteolytic lesion
por: Traore, Ousmane, et al.
Publicado: (2021)

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases
por: Ersek, Adel, et al.
Publicado: (2012)

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis
por: Lee, Sun Kyoung, et al.
Publicado: (2017)

The Hedgehog Pathway Conditions the Bone Microenvironment for Osteolytic Metastasis of Breast Cancer
por: Das, Shamik, et al.
Publicado: (2012)

The Impact of Metal Ion Exposure on the Cellular Behavior of Human Osteoblasts and PBMCs: In Vitro Analyses of Osteolytic Processes
por: Jonitz-Heincke, Anika, et al.
Publicado: (2017)

Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip
por: Agheli, Aref, et al.
Publicado: (2015)

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
por: Coniglio, Salvatore J.
Publicado: (2018)

Multiple Roles of Angiopoietin-Like 4 in Osteolytic Disease
por: Knowles, Helen J.
Publicado: (2017)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Osteolytic Skull Lesions–Our Experience
por: Sandeep, B. V., et al.
Publicado: (2017)

Preventing osteolytic lesions and osteomyelitis in multiple myeloma
por: Dao, Aiken, et al.
Publicado: (2022)

Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.
por: Fernando, I. N., et al.
Publicado: (1994)

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.
por: Lønning, P. E., et al.
Publicado: (1991)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells
por: Ruppender, Nazanin S., et al.
Publicado: (2010)

Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
por: Choi, Bongkun, et al.
Publicado: (2014)

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
por: MacNeill, F. A., et al.
Publicado: (1992)

Fin ray branching is defined by TRAP(+) osteolytic tubules in zebrafish
por: Cardeira-da-Silva, João, et al.
Publicado: (2022)

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
por: ZINONOS, IRENE, et al.
Publicado: (2014)

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases
por: Drescher, Florian, et al.
Publicado: (2020)

Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis
por: Kovacheva, Marineta, et al.
Publicado: (2020)

Osteolytic Bone Lesions – A Rare Presentation of AML M6
por: Geetha, N., et al.
Publicado: (2015)

Idiopathic Hypertrophic Spinal Pachymeningitis with an Osteolytic Lesion
por: Jee, Tae Keun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0cldqu5dtnlkjkg4dchm6tv1nn